Xifeng Wu
Impact in
- Cancer Research top 0.1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Carcinogens and Genotoxicity Assessment
- Molecular Biology top 0.2%
- DNA Repair Mechanisms
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Circular RNAs in diseases
Papers in
- Cancer Research 163
- Carcinogens and Genotoxicity Assessment 45
- Cancer-related molecular mechanisms research 43
- MicroRNA in disease regulation 39
- Cancer Genomics and Diagnostics 31
-
- Epigenetics and DNA Methylation 68
- DNA Repair Mechanisms 66
- RNA modifications and cancer 46
- Co-authors
- Margaret R. SpitzJian GuYuanqing YeJie LinColin P. DinneyQiong DongChristopher I. AmosHushan Yang
- Journals
- Carcinogenesis (41 papers)Cancer Research (33 papers)Cancer (30 papers)Cancer Epidemiology Biomarkers & Prevention (28 papers)Clinical Cancer Research (21 papers)
- Partner nations
- United StatesChinaTaiwan
In The Last Decade
Xifeng Wu
446 papers receiving 17.0k citations
Hit Papers
Peers
Comparison fields: 5 of 181
- Cancer Research 5.1k
- Molecular Biology 10.1k
- Oncology 3.5k
- Pulmonary and Respiratory Medicine 2.8k
- Pathology and Forensic Medicine 1.2k
Countries citing papers authored by Xifeng Wu
This map shows the geographic impact of Xifeng Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xifeng Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xifeng Wu more than expected).
Fields of papers citing papers by Xifeng Wu
This network shows the impact of papers produced by Xifeng Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xifeng Wu. The network helps show where Xifeng Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xifeng Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 12 | |
| 2 | 2022 | 7 | |
| 3 | 2019 | 8 | |
| 4 | 2017 | 3 | |
| 5 | 2017 | 11 | |
| 6 | 2016 | 31 | |
| 7 | 2015 | 17 | |
| 8 | 2015 | 22 | |
| 9 | 2014 | 24 | |
| 10 | 2014 | 50 | |
| 11 | 2013 | 15 | |
| 12 | 2012 | 25 | |
| 13 | 2012 | 11 | |
| 14 | 2012 | 56 | |
| 15 | 2012 | 27 | |
| 16 | 2011 | 53 | |
| 17 | 2010 | 67 | |
| 18 | 2009 | 32 | |
| 19 | 2009 | 63 | |
| 20 | 2009 | 44 |
About Xifeng Wu
Xifeng Wu is a scholar working on Cancer Research, Molecular Biology, Aging, Oncology and Pulmonary and Respiratory Medicine, having authored 461 papers that have together received 17.3k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (68 papers), DNA Repair Mechanisms (66 papers), Bladder and Urothelial Cancer Treatments (54 papers), RNA modifications and cancer (46 papers), Carcinogens and Genotoxicity Assessment (45 papers), Cancer-related molecular mechanisms research (43 papers), MicroRNA in disease regulation (39 papers) and Cancer Genomics and Diagnostics (31 papers). The work is most often cited by research in Cancer Research (5.1k citations), Molecular Biology (10.1k citations), Oncology (3.5k citations), Pulmonary and Respiratory Medicine (2.8k citations) and Pathology and Forensic Medicine (1.2k citations). Xifeng Wu has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Margaret R. Spitz, Jian Gu, Yuanqing Ye, Jie Lin, Colin P. Dinney, Qiong Dong, Christopher I. Amos, Hushan Yang, Maosheng Huang and H. Barton Grossman. Their work appears in journals such as Carcinogenesis, Cancer Research, Cancer, Cancer Epidemiology Biomarkers & Prevention and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.